High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patients

被引：0
|
作者：
Hoffmann, O.
Goebel, A.
Bittner, A-K
Rauner, M.
Hofbauer, L. C.
Kimmig, R.
Kasimir-Bauer, S.
Rachner, T. D.
机构：
[1] Univ Hosp Essen, Essen, Germany
[2] Tech Univ Dresden, Med Ctr, Dresden, Germany
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-09-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-09-08
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Circulating tumor cells in non-metastatic triple-negative breast cancer
    Karhade, Mandar
    Hall, Carolyn
    Mishra, Priyankana
    Anderson, Amber
    Kuerer, Henry
    Bedrosian, Isabelle
    Krishnamurthy, Savitri
    Lucci, Anthony
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (02) : 325 - 333
  • [32] Molecular profiling of circulating tumor cells in non-metastatic breast cancer.
    Forte, Victoria
    Zhu, Weizhu
    Barrak, Dany
    Ring, Alexander
    Punj, Vasu
    Tripathy, Debu
    Yu, Min
    Raghavendra, Akshara
    Yang, Gloria
    Lang, Julie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Clinical characteristics and survival outcomes in patients with a high PSA and non-metastatic prostate cancer
    Huang, Cheng-Yu
    Chen, Chung-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 181 - 186
  • [34] Non-metastatic breast cancer specific-survival of patients after treatment with adjuvant chemotherapy
    Duarte Cintra, Jane Rocha
    Guerra, Maximiliano Ribeiro
    Bustamante-Teixeira, Maria Teresa
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2008, 54 (04): : 339 - 346
  • [35] Increased neutrophil-lymphocyte ratio independently predicts poor survival in non-metastatic triple-negative breast cancer patients
    Qiu, Xiangting
    Song, Yucui
    Cui, Yanxiang
    Liu, Yan
    IUBMB LIFE, 2018, 70 (06) : 529 - 535
  • [36] Coagulation factor levels in non-metastatic colorectal cancer patients
    Battistelli, S.
    Stefanoni, M.
    Lorenzi, B.
    Dell'Avanzato, R.
    Varrone, F.
    Pascucci, A.
    Petrioli, R.
    Vittoria, A.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (01): : 36 - 41
  • [37] Outcome of non-metastatic male breast cancer: 222 patients
    Arslan, U. Y.
    Aslan, F.
    Ayhan, M.
    Akdeniz, N.
    Tahtaci, G.
    Cinkir, H. Yesil
    Inanc, M.
    Imamoglu, G. I.
    Alkis, N.
    Turan, N.
    Kaplan, M. A.
    Ozdemir, N. Y.
    Oksuzoglu, O. B. Cakmak
    ANNALS OF ONCOLOGY, 2019, 30 : 67 - 67
  • [38] In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival
    Bittner, A-K
    Goebel, A.
    Hoffmann, O.
    Rauner, M.
    Hofbauer, L. C.
    Kimmig, R.
    Kasimir-Bauer, S.
    Rachner, T. D.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Outcome of non-metastatic male breast cancer: 118 patients
    Ülkü Yalçıntaş Arslan
    Berna Öksüzoğlu
    Nuriye Özdemir
    Sercan Aksoy
    Necati Alkış
    Ayşe Gök
    Mehmet Ali Kaplan
    Mahmut Gümüş
    Veli Berk
    Doğan Uncu
    Meltem Baykara
    Dilşen Çolak
    Ümmügül Üyetürk
    İbrahim Türker
    Abdurrahman Işıkdoğan
    Medical Oncology, 2012, 29 : 554 - 560
  • [40] Outcome of non-metastatic male breast cancer: 118 patients
    Arslan, Ulku Yalcintas
    Oksuzoglu, Berna
    Ozdemir, Nuriye
    Aksoy, Sercan
    Alkis, Necati
    Gok, Ayse
    Kaplan, Mehmet Ali
    Gumus, Mahmut
    Berk, Veli
    Uncu, Dogan
    Baykara, Meltem
    Colak, Dilsen
    Uyeturk, Ummugul
    Turker, Ibrahim
    Isikdogan, Abdurrahman
    MEDICAL ONCOLOGY, 2012, 29 (02) : 554 - 560
12345